April 2026

A special cycle, not a demand turn

The ifo climate fell from -25.0 in March to -29.0 in April. Current conditions improved slightly, but expectations dropped to -30.9. About one-third of surveyed companies reported shortages of intermediate materials. At the same time, some German suppliers benefited from missing imports and precautionary buying.

This created a special cycle: orders rose because supply chains looked unsafe, not because final demand strengthened. The falsification test is inventory. If customer stock-building was the mechanism, orders would fade when routes normalized or warehouses filled. Companies themselves did not expect the rise to last.

The latest comprehensive VCI data still described the fourth quarter of 2025, with chemical output down 2.4% quarter on quarter, chemical sales down 5.5% year on year, and utilization at 72.5%. April's survey therefore improved no hard-data baseline.

Sources: ifo April chemical climate, VCI Q4 2025 report

Energy and the industrial electricity subsidy

Producer energy prices rose 2.4% month on month and 2.0% year on year in April, following March's larger jump. Energy had ceased to be a favorable base effect.

Germany notified the industrial electricity aid on April 1. The European Commission approved it on April 16. For eligible energy-intensive companies, the scheme can cover 50% of eligible electricity costs, subject to a 5 cent/kWh floor, conditions, and reinvestment requirements. Network charges, taxes, and levies remain outside the five-cent floor. The support applies to accounting years 2026–2028.

That architecture produces three boundaries. First, eligibility is selective. Second, the relief is conditional rather than automatic. Third, it changes only one line of the Standort D cost stack. Strompreiskompensation remained a separate instrument for eligible indirect carbon costs. Labor, bureaucracy, maintenance, and underutilization remained.

Sources: European Commission approval decision, Federal government energy-price explainer, Destatis producer prices, April

Green Deal, REACH, and federal subsidies

April's central regulatory event was the electricity approval. The broader Green Deal debate shifted toward industrial execution: local production, resilience, and decarbonization were increasingly treated as linked rather than competing objectives. Yet the evidence from chemical plants suggested a sequencing problem. Firms need competitive operating costs before they can finance low-carbon replacement assets.

No material new REACH restriction decision changed the sector's cost base in April. The revised Classification, Labelling and Packaging rules remained on the implementation horizon, with major obligations due from July. For compliance teams, the absence of a new headline did not mean a quiet workload.

Sources: European Commission REACH overview, European Commission revised CLP rules

BASF's quarterly result was better than the macro mood. Net income rose to €927 million, and EBITDA before special items reached €2.36 billion, down only modestly from the prior year. Yet special charges included the continuing Ludwigshafen program. Earnings resilience was purchased partly through a smaller German cost base.

Wacker's result was even more striking: EBITDA rose 45% despite lower sales. The drivers were PACE savings, project timing, and customer orders brought forward. Those are valid earnings. They are weak evidence for a durable volume cycle.

Sources: BASF Q1 2026, Wacker Q1 2026

April's most concrete Standort D innovation signal was BASF's agreement with Schütz for a highly automated intermediate-bulk-container production and logistics facility at Ludwigshafen. The project used the Verbund's infrastructure and customer density. It was a reminder that Germany can still win when integration creates a cost advantage that energy alone does not erase.

The German Biotech Days in Leipzig emphasized the convergence of biotechnology, artificial intelligence, advanced materials, and microelectronics. That convergence is strategically credible. Its scaling constraint remains less glamorous: permitting, shared infrastructure, and the cost of industrial utilities.

Sources: Chemical plant projects, March/April publication, CHEManager — German Biotech Days

One-month equity performance

Method: March month-end to April month-end Xetra closes, unadjusted and rounded. Up is above +2%; Down below -2%; otherwise Neutral.

Wacker's move matched the earnings surprise. BASF and Evonik also benefited from evidence that cost programs could protect EBITDA. Bayer, Lanxess, and Henkel showed the other half of the tape: balance-sheet, demand, and transaction concerns remained company-specific.

Analyst-rating tape

No verified Deutsche Bank or Goldman Sachs upgrade or downgrade for the eight companies was found in the April window. Results-day target-price adjustments reported by market services are not classified here as rating changes unless the underlying recommendation changed and a primary or attributable bank source could be verified.

Price sources: BASF, Bayer, Covestro, Evonik, Lanxess, Wacker, Henkel, Merck KGaA. Rating source: Deutsche Bank recommendation history.

Headline and Mood Index

Media method: Public headlines and indexed snippets from Handelsblatt, FAZ, CHEManager, and Börsen-Zeitung were reviewed for vocabulary and emphasis. Paywalled or crawler-restricted text was not used as the sole support for a factual claim.

The month's language was paradoxical. Financial headlines discussed resilient earnings and possible beneficiaries of disrupted Asian supply. Industrial headlines discussed a three-year sentiment low. Handelsblatt's indexed coverage put the collapse in the title; CHEManager continued to frame European competitiveness as an emergency.

Sources: Handelsblatt — three-year chemical low, Tagesschau — BASF and the Iran-war special cycle, CHEManager — Lone Voices in the Desert

What Would Change the View?

The subsidy can improve the index only when eligibility, realized relief, and investment behavior become observable. A rise in orders caused by missing imports is insufficient. April would mark a bottom only if expectations recovered after inventories normalized. At month-end, management teams were telling us the opposite.